Late-onset pompe disease: What is the prevalence of limb-girdle muscular weakness presentation?

10Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Pompe disease is an inherited disease caused by acid alpha-glucosidase (GAA) deficiency. A single center observational study aimed at assessing the prevalence of late-onset Pompe disease in a high-risk Brazilian population, using the dried blood spot test to detect GAA deficiency as a main screening tool. Dried blood spots were collected for GAA activity assay from 24 patients with “unexplained” limb-girdle muscular weakness without vacuolar myopathy in their muscle biopsy. Samples with reduced enzyme activity were also investigated for GAA gene mutations. Of the 24 patients with dried blood spots, one patient (4.2%) showed low GAA enzyme activity (NaG/AaGIA: 40.42; %INH: 87.22%). In this patient, genetic analysis confirmed two heterozygous mutations in the GAA gene (c.-32-13T>G/p.Arg854Ter). Our data confirm that clinicians should look for late-onset Pompe disease in patients whose clinical manifestation is an “unexplained” limb-girdle weakness even without vacuolar myopathy in muscle biopsy.

Cite

CITATION STYLE

APA

Lorenzoni, P. J., Kay, C. S. K., Higashi, N. S., D’Almeida, V., Werneck, L. C., & Scola, R. H. (2018). Late-onset pompe disease: What is the prevalence of limb-girdle muscular weakness presentation? Arquivos de Neuro-Psiquiatria, 76(4), 247–251. https://doi.org/10.1590/0004-282x20180018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free